© 2018 by Moonlight Therapeutics

May 7, 2019

National Institutes of Health Awards Moonlight Therapeutics with a $2.5 Million Grant to Advance Development of Peanut Allergy Treatment 

Moonlight Therapeutics, Inc., a biotechnology company developing treatments for food allergies, announced today the receipt of $2.5 million in funding for preclinical studies and product development that will enable preparations for a clinical trial for its lead program in peanut allergy. This funding was awarded through a highly competitive Small Business Technology Transfer (STTR) Fast Track grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH).  Click for more details.

Jan 10, 2018

Moonlight Therapeutics presents at SEBio Investor Forum

Moonlight Therapeutics Inc will give a corporate presentation at Biotech Showcase 2018, an independent investor conference for public and private life sciences companies.

Jan 2018

Moonlight Therapeutics joins ATDC Accelerate 

The Advanced Technology Development Center (ATDC) at Georgia Tech is Georgia’s technology incubator. Founded in 1980, ATDC has developed a global reputation for fostering technological entrepreneurship. Forbes named ATDC to its list of “Incubators Changing the World” in 2010 and 2013, alongside Y Combinator and the Palo Alto Research Center.

Nov 15 2017

Moonlight Therapeutics presents at SEBio Investor Forum

Moonlight Therapeutics is selected to present at Southeast BIO (SEBIO) Investor Forum